Co-Tareg 160/12.5 Mg 14 Tablets

Co-Tareg 160/12.5 Mg 14 Tablets

Description:

Co-Tareg 160/12.5 mg is a prescription antihypertensive medicine combining valsartan (an angiotensin II receptor blocker) and hydrochlorothiazide (a thiazide diuretic) in film-coated tablet form. It is used to lower high blood pressure (hypertension) in adults when monotherapy is insufficient, helping to reduce the risk of serious cardiovascular events such as stroke and heart attack. By relaxing blood vessels and increasing the excretion of excess salt and water, Co-Tareg provides effective, long-term blood pressure control under medical supervision.

Indications:

• Treatment of essential hypertension in adults.
• Management of high blood pressure in patients not adequately controlled by valsartan or hydrochlorothiazide alone.
• Helps reduce the risk of complications related to uncontrolled hypertension, such as stroke, heart attack, and kidney damage (as part of an overall cardiovascular risk management plan).
• May be used in patients requiring combination therapy with an angiotensin II receptor blocker and a thiazide diuretic as determined by a physician.

Active Ingredients / Key Components:

• Valsartan – 160 mg per film-coated tablet (angiotensin II receptor blocker, ARB).
• Hydrochlorothiazide – 12.5 mg per film-coated tablet (thiazide diuretic).
• Other excipients: Full list of inactive ingredients (such as tablet core and coating components, colorants, and stabilizers) is not provided in the available data. Please refer to the official package leaflet for the complete excipient list.

Dosage & Administration / How to Use:

• Use only as prescribed by a physician experienced in the management of hypertension.
• Typical adult dose: 1 tablet (160 mg valsartan / 12.5 mg hydrochlorothiazide) once daily, or as directed by your doctor. Dose may be adjusted based on blood pressure response and clinical condition.
• Route of administration: Oral.
• Swallow the tablet whole with a glass of water; do not crush or chew.
• Can be taken with or without food, preferably at the same time each day to maintain consistent blood levels.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
• Do not stop taking Co-Tareg abruptly without consulting your doctor, as this may cause your blood pressure to rise again.
• Regular monitoring of blood pressure, kidney function, and electrolytes (such as potassium, sodium, and magnesium) is recommended during treatment.

Clinical Benefits:

• Provides dual blood pressure control by blocking the effects of angiotensin II (vasoconstrictor) and promoting diuresis (removal of excess salt and water).
• Helps reduce elevated blood pressure, thereby lowering the risk of stroke, heart attack, and other cardiovascular complications when used as part of a comprehensive treatment plan.
• Once-daily dosing supports convenient, long-term management of hypertension and may improve treatment adherence.
• Combination therapy can be more effective than single-agent treatment in patients not adequately controlled by monotherapy.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to valsartan, hydrochlorothiazide, other sulfonamide-derived drugs, or any component of the product.
• Contraindicated in severe renal impairment, anuria, or severe hepatic impairment, and in patients with refractory hypokalemia, hypercalcemia, or symptomatic hyperuricemia/gout related to thiazide use.
• Do not use during the second and third trimesters of pregnancy; ARBs can cause injury and death to the developing fetus. If pregnancy is detected, discontinue Co-Tareg as soon as possible.
• Use is generally not recommended during breastfeeding unless clearly needed and after medical evaluation.
• Use with caution in patients with renal artery stenosis, heart failure, liver disease, electrolyte imbalances (such as low sodium, low or high potassium, low magnesium), diabetes, gout, or a history of severe allergic reactions.
• Concomitant use with potassium supplements, potassium-sparing diuretics, or salt substitutes containing potassium may increase the risk of hyperkalemia; monitor potassium levels.
• May interact with other medications such as NSAIDs, lithium, other antihypertensives, and antidiabetic drugs; dose adjustments and monitoring may be required.
• Hydrochlorothiazide may increase sensitivity to sunlight (photosensitivity); use sun protection and avoid excessive sun exposure.
• May cause dizziness or fatigue; caution is advised when driving or operating machinery until you know how the medicine affects you.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, diabetes, gout, or electrolyte disturbances.
• Not intended to diagnose, treat, cure, or prevent any disease outside the approved indications.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dizziness, headache, fatigue, low blood pressure (hypotension), and mild gastrointestinal disturbances such as nausea or abdominal discomfort.
• Hydrochlorothiazide-related effects may include increased urination, changes in electrolyte levels (low potassium, low sodium, low magnesium), increased uric acid (which may trigger gout in susceptible individuals), and increased blood glucose in some patients.
• Less common but serious side effects can include severe hypotension, kidney function impairment, severe electrolyte imbalances, allergic reactions (rash, itching, swelling, difficulty breathing), or photosensitivity reactions.
• Very rare but serious reactions such as angioedema (swelling of face, lips, tongue, or throat) require immediate medical attention and discontinuation of the drug.
• If you experience persistent dizziness, fainting, muscle weakness, irregular heartbeat, difficulty breathing, swelling, or any severe or unusual symptoms, seek medical attention promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.

Specifications:

• Product type: Prescription antihypertensive medicine.
• Form: Film-coated tablets.
• Strength per tablet: 160 mg valsartan + 12.5 mg hydrochlorothiazide.
• Pack size: 14 tablets per pack.
• Intended use: Adult patients with essential hypertension requiring combination therapy, under medical supervision.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.